Xencor (XNCR) Change in Account Payables (2013 - 2026)
Xencor (XNCR) posted quarterly Change in Account Payables of -$2.9 million for Q1 2026, down 405.46% year-over-year from $939900.9 in Q1 2025, and down 269.78% quarter-over-quarter from $1.7 million in Q4 2025.
Analysis
Xencor (XNCR) Change in Account Payables (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Change in Account Payables for 14 consecutive years, with -$2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 405.46% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$6.3 million (down 3575.56% YoY), while the FY2025 annual figure was -$4.0 million, down 238.95% from the prior year.
- Change in Account Payables slipped to -$2.9 million in Q1 2026 per XNCR's latest filing, from $1.7 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $5.3 million in Q1 2023 and bottomed at -$9.5 million in Q3 2025.
- Historically, Change in Account Payables has averaged -$239176.5 across 5 years, with a median of -$568000.0 in 2025.
- On a YoY basis, Change in Account Payables climbed as much as 2630.64% in 2025 and fell as far as 422.44% in 2025.
- Xencor's Change in Account Payables stood at -$4.5 million in 2022, then jumped by 76.75% to -$1.1 million in 2023, then sank by 90.98% to -$2.0 million in 2024, then surged by 184.09% to $1.7 million in 2025, then tumbled by 269.78% to -$2.9 million in 2026.
- Business Quant data shows XNCR's Change in Account Payables at -$2.9 million in Q1 2026, $1.7 million in Q4 2025, and -$9.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | 4.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.51 Mn |
| Mar 31, 2026 | -2.87 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | -9.45 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | -568,000.00 |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | -173,000.00 |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | -1.05 Mn |
| Sep 30, 2023 | 870,000.00 |
| Jun 30, 2023 | -1.25 Mn |
| Mar 31, 2023 | 5.25 Mn |
| Dec 31, 2022 | -4.53 Mn |
| Sep 30, 2022 | -1.13 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | -2.10 Mn |
| Dec 31, 2021 | 4.87 Mn |
| Sep 30, 2021 | 2.02 Mn |